The Capnocytophaga are inhabitants of the hypoxic human gingival crevice that are normally prevented by neutrophils from causing periodontal and systemic infection. To identify potential nonoxidative bactericidal mechanisms against Capnocytophaga within human neutrophils, gel filtration chromatography was used to fractionate neutrophil granule extracts.
Introduction
The Capnocytophaga Spp. are gram-negative, capnophilic, facultative, gliding bacteria indigenous to dental plaque (1) . In the oral cavity, Capnocytophaga have been associated with localized juvenile periodontitis, a rapid, destructive form ofperiodontal disease associated with intrinsic defects in neutrophil This work was presented in part at the 68th General Session of the International Association for Dental Research, Cincinnati, OH, March [9] [10] [11] [12] [13] [14] 1990 , and was published in abstract form ( chemotaxis (2) . Conversely, oral infections by Capnocytophaga Spp. have apparently resulted in reversible, acquired systemic defects in neutrophil chemotaxis (3) . In addition to their association with periodontal disease, Capnocytophaga are capable of producing systemic infection in man (4) ; and notably, in association with granulocytopenia (5, 6) . Many blood isolates ofCapnocytophaga are insensitive to serum bactericidal activity (7) . Thus, it can be concluded that neutrophils must play an important role in controlling both periodontal and systemic infection by the genus Capnocytophaga.
The molecular aspects of phagocyte interactions with Capnocytophaga Spp. have yet to be described. Neutrophils are capable of killing Capnocytophaga in vitro (8) . In general, neutrophils kill bacteria by both oxidative and nonoxidative mechanisms (9) . The nonoxidative mechanisms include (a) cationic peptides known as the defensins; (b) the neutral serine protease family (NSP)' including cathepsin G, elastase, azurocidin (possibly identical to CAP37), proteinase 3, and p29b (possibly identical to AGP7 and proteinase 3); (c) the bactericidal/permeability-increasing protein (B/PI); (d) enzymes such as lysozyme; and (e) cofactor-binding proteins including apolactoferrin, and possibly, cobalophilin (10) (11) (12) (13) (14) (15) (16) (17) (18) . Many of these substances kill bacteria in a manner independent of enzymatic activity (10, 12, (15) (16) (17) 19) . Cathepsin G, a chymotrypsin-like enzyme, has been reported to kill certain bacteria nonenzymatically (15, 20, 21, 22) . As such, the function ofthe chymotryptic activity of cathepsin G is unknown.
We examined the bactericidal activity oflysosomal constituents from human neutrophils against Capnocytophaga under aerobic and anaerobic conditions, and identified cathepsin G as one ofthe primary oxygen-independent bactericidal mechanisms. Furthermore, we demonstrated that an active enzyme was required for the killing of Capnocytophaga by cathepsin G.
Methods
Bacteria and growth conditions. Capnocytophaga sputigena ATCC 33123, C. gingivalis ATCC 33124, C. ochracea ATCC 27872, and Escherichia coli were grown overnight at 370C, in 5% C0J95% air on chocolate agar consisting of trypticase soy agar (BBL Microbiology Systems, Cockeysville, MD), 0.1% yeast extract (Difco Laboratories, Detroit, MI), 5% heat-hemolyzed defibrinated horse blood (Mission Laboratories, Fontana, CA) 0.002% equine hemin III (Sigma Chemical Co., St. Louis, MO), 0.0001% menadione (Sigma Chemical Co.), and IsoVitale X supplement (BBL Microbiology Systems). E. coli ML-35 was a generously provided by Dr. R. I. Lehrer, UCLA School of Medicine. Bacteria were removed from plates and placed in trypticase soy broth containing 0. 1% yeast extract, 0.002% equine hemin III, 0.0001% menadione, and 0.1% sodium bicarbonate (TSB), grown to mid log growth phase (109 cells/ml), adjusted to 108 cells/ml in TSB, and diluted 1:100 in a buffer consisting of 10 mM sodium phosphate, pH 7.0, producing a final 1% vol/vol concentration of TSB. In anaerobic studies, the organisms were grown for 24 h in an anaerobic chamber (Forma Scientific, Marietta, OH) containing 85% N2, 10% H2, and 5% C02; inoculated into anaerobically pre-equilibrated TSB, grown to mid log phase; and inoculated into anaerobically pre-equilibrated 10 mM sodium phosphate as described above. The bacterial cell concentration was determined turbidometrically (optical density at 540 nm of 0.1-0.3 was equivalent to 109 cells/ml).
Preparation ofPMN granules. Fresh human neutrophils were purified from granulocyte-enriched, leukocyte concentrates (Hemacare, Sherman Oaks, CA), using gelatin flotation, hypotonic lysis and Percoll sedimentation (23 , and 0.0 14 M 2-mercaptoethanol, pH 7.5, was then added (1.1 part per 10 parts hypotonic buffer). This suspension was centrifuged at 300 g for 6 min to remove nucleii, ruptured and unruptured cells, and other debris. The turbid, granule-laden suspension was then chilled to 4°C and centrifuged at 32,000 g, 4°C, for 20 min. The dark green pellets were stored at -85°C until needed.
Preparation ofgranule extracts andpurifiedgranuleproteins. Granules were suspended in 0.5% cetyltrimethylammonium bromide, 0.02 M sodium acetate, 0.2 M NaCl, pH 4.7, and disrupted by homogenization in a Duall glass homogenizer at 4°C. The suspension was centrifuged at 32,000 g for 20 min at 4°C, and the clear green supernatant, containing 78.5 mg protein, was collected and 60 mg protein was loaded immediately on a Sephadex G-100 (Pharmacia-LKB Biotechnology, Piscataway, NJ) gel filtration column, 1.6 X 100 cm, equilibrated in 0.02 M sodium acetate, 0.2 M NaCl, pH 4.7 (Buffer A), 4°C. The flow rate was 12 ml/h, and 3-ml fractions were collected.
Medium pressure liquid chromatography (FPLC). Further isolation of microbicidal substances was achieved using medium pressure liquid chromatography (FPLC) by applying fraction D to a Mono-S HR 5/5 column (Pharmacia-LKB Biotechnology) equilibrated in Buffer A. Buffer B consisted of0.02 M sodium acetate, 2.0 M NaCl, pH 4.7, and was used to achieve a salt gradient. Final separation of proteins for amino acid analysis and NH2-terminal peptide sequence was achieved by reversed-phase FPLC using a ProRPC HR 5/2 column (Pharmacia-LKB Biotechnology) equilibrated with 0.1% trifluoroacetic acid in water and a gradient formed by 0.1% trifluoroacetic acid in acetonitrile.
Microassays. Lysozyme (E.C. 3.2.1.77) was assayed by monitoring the decrease in optical density at 450 nm of a suspension of cell wall fragments ofMicrococcus lysodeikticus in 0.1 M phosphate buffer, pH 7.0 at 25°C (24) . The lysozyme assay was performed using a kinetic microplate reader (Molecular Devices, Palo Alto, CA). Cathepsin G and elastase endpoint assays were also performed in microtiter format. In the elastase assay, samples were suspended in 0.1% Brij 35, 0.05 M Tris-HCl, 1.0 M NaCI, and 0.1 % trisodium EDTA, pH 8.5. The cathepsin G assay was performed in 0.1% Brij 35, 0.05 M Tris-HC1, and 0.1% trisodium EDTA, pH 7.5. The reaction was initiated by the addition of substrate N-benzyloxycarbonyl-L-alanyl-2-naphthyl ester, 50 ,g/ml, for elastase and N-benzoyl-D,L-phenylalanyl-2-naphthyl ester, 50 ,g/ ml, for cathepsin G (25) . This mixture was incubated for 90 min at 370C, and terminated by the addition of soybean trypsin inhibitor at a final concentration of 300 jig/ml. Released naphthal was detected by coupling to fast garnet, added at a final concentration of40 /Ag/ml. The sample was assayed spectrophotometrically at 520 nm using the microplate reader. Protein concentration was determined in microtiter format by the method of Bradford (26) .
SDS-PAGE. SDS-PAGE was performed using the method of Laemmli (27) with a 12% resolving gel (12% T, 2.6% C) and a 3% stacking gel (3% T, 2.6% C) in a mini-gel system (Hoefer Scientific Instruments, San Francisco, CA). Electrophoresis was initiated by applying 53 V until the tracking dye formed a narrow band in the stacking gel, after which the voltage was increased and maintained at a constant 105 V (initially, 12.5 mA/gel). Gels were stained for protein using 0.125% Coomassie blue R-250 (Sigma Chemical Co.) in 50% methanol: 10% acetic acid, and destained sequentially with 50% methanol: 10% acetic acid followed by 5% methanol: 7% acetic acid. The amount of sample added per was 5 Mg protein for Coomassie stain procedures and 2.5 Mg protein for blotting. Acid-Urea Polyacrylamide Gel Electrophoresis (AU-PAGE). AU-PAGE was performed in "tall" minigels (Hoefer Scientific Instruments) by a modification of the method of Panyim and Chalkley (28) . Briefly, 12.5% acrylamide gels were modified to incorporate 3 M urea and preelectrophoresed in 5% acetic acid at 150 V for 2 h. Samples were dissolved in deionized 6 M urea containing 7% acetic acid, and subsequent electrophoresis was performed at 200 V until the methylene green tracking dye eluted from the bottom ofthe gel. Gels were stained in 0.125% Coomassie Blue R-250 in 40% methanol, 15% formaldehyde, 5% acetic acid, and destained in 25% methanol, 3.7% formaldehyde as previously described (19) .
Bactericidal assay. Bacteria were incubated with granule extract materials in a total volume of 40 1M in 0.01 M sodium phosphate, pH 7.0, containing 1% vol/vol TSB, and maintained at 370C (using a temperature block), unless otherwise indicated. When indicated, inhibitors were preincubated with the granule fractions for 10-120 min before admixture with bacteria. Additives used included PMSF (Sigma Chemical Co.), N-a-tosyl-phenylalanine-chloromethyl ketone (TPCK; Sigma Chemical Co.), N-benzyloxycarbonyl-glycylleucylphenylalanyl-chloromethyl ketone (Z-GLPCK; Enzyme System Products, Dublin, CA), methoxy-succinyl-alanylalanylprolylvalyl-chloromethyl ketone (N-MSAAPVCK; Sigma Chemical Co.), a-I-antitrypsin (Sigma Chemical Co.), and chymotrypsin A4 (Boehringer-Mannheim Biochemicals, Indianapolis, IN). TPCK is relatively unreactive against cathepsin G, but Z-GLPCK and N-MSAAPVCK are highly specific inhibitors against cathepsin G and elastase, respectively (29) . The bactericidal reaction was terminated by 1:10 dilution in 10 mM sodium phosphate, pH 7.0, and the resultant suspension was immediately spread on Laked blood agar plates using a Spiral plater (Spiral Systems, Bethesda, MD). Anaerobic assays were modified such that all reagents and cells were equilibrated anaerobically as described (30), under an atmosphere containing 85% N2, 10% H2, and 5% CO2. After 48-72 h of incubation, CFU were enumerated. Bactericidal activity in dose-response assays was quantified as the logl0 reduction in CFU, and calculated by the formula: 5l[og1o killing] = log10 no -logl0 n,, where n is the bacterial CFU/ml at time 0 or time t. The no was adjusted to 2-5 X I05 CFU/ml in all cidal assays. Variance of b is described, where applicable, as a maximum estimate of the standard deviation, by the formula SD5 = log10 n, -log10 (nt -SD), where SD is the standard deviation of the CFU/ml.
Diisopropylfluorphosphate(DFP) inactivation. Purified human neutrophil cathepsin G was also obtained from commercial sources (Biodesign International, Kennebunkport, ME). This cathepsin G was > 98% pure as assessed by SDS-PAGE (according to the vendor) and was virtually identical to subfractions D8-D1 1 by our own SDS-PAGE analysis. Serine protease activity of purified commercial cathepsin G, 500 Mg, was inactivated with 20 mM DFP (Sigma Chemical Co.), in 50 mM phosphate, pH 7.0, 2 h, on ice. DFP was eliminated by microdialysis against three exchanges of distilled water for 6 h at 4°C. Reversed-phase FPLC. Reversed-phase FPLC was performed using a ProRPC HR 5/2 (Pharmacia-LKB Biotechnology) column (Cl-C4 equivalent). Subfraction D8-Dl I was applied usinj
The column was permitted to equilibrate in 0.1% Elution was performed using a 20-ml lineargradien nitrile containing 0.1% trifluoroacetic acid. Sample by vacuum centrifugation using a SpeedVac (SE Farmingdale, NY).
Amino acid composition. The amino acid comp sample was analyzed with and without performic f samples were hydrolyzed in 6 N HC1, deoxygenate 24 h at100IC. The samples were analyzed using ai acid analyzer ( cid, and concen- (Fig. 3, inset) . SubfractionDl The amino acid composition of subfraction D4 was consistent __________ TTwith elastase (Table II) . (Fig. 4) Bactericidal activity ofsubfraction D9 as afunction ofdose, time, ionic strength, and pH. We next observed the effect of dose, time, ionic strength, and pH on killing by subfraction D9. The killing of C. sputigena ATCC 33123 by subfraction D9 followed exponential kinetics; however, a shoulder was suggested at 50 ,g/ml (Fig. 5) . A dramatic dose dependency was evident, and virtually no killing was observed at 20 yg/ml. Both ionic conditions and pH influenced the bactericidal activity of subfraction D9 (Fig. 6) . Killing was virtually abolished above 20 mM NaCl. Alkaline pH enhanced the killing ofC. sputigena ATCC 33123, but killing occurred throughout the pH range tested (pH 6.0-8.0).
Enzymatic activity and killing. We tested the effect of heat (90'C, 10 min), PMSF, TPCK, Z-GLPCK, and N-MSAAPVCK on the bactericidal activity of fraction D and subfraction D9 against C. sputigena ATCC 33123. Heating fraction D or subfraction D9 to 90'C for 10 min resulted in a 95.6-100% reduction in enzymatic activity and a complete loss of bactericidal activity. The bactericidal activity of subfraction D9 could not be restored by the addition of 100 ,g/ml chymotrypsin A4. When fraction D, 100 ,g/ml, and subfraction D9 were preincubated with PMSF for 10 min, cidal activity against C. sputigena ATCC 33123 was inhibited at PMSF concentrations above 10 ,ug/ml (Fig. 7) . Inhibition of enzymatic activity by PMSF closely paralleled the inhibition ofbactericidal activity. The specific inhibitor of cathepsin G, Z-GLPCK, partially reduced bactericidal activity (Table III) . The elastase inhibitor, N-MSAAPVCK, also modestly depressed killing of fraction D but not subfraction D9, and its effect was much less than Z-GLPCK. Chymotryptic esterolytic activity was inhibited by Z-GLPCK but not N-MSAAPVCK. The inhibition ofenzymatic activity by Z-GLPCK was 96±4%, respectively. No inhibition of cidal activity was observed in the presence of TPCK. No inhibition of cidal activity was observed if cells were preincubated with 100 ,g/ml PMSF for 2 h, washed, and exposed to fraction D. In comparison, E. coli ML-35 was also sensitive to the bactericidal effects of D9, exhibiting a bloglo of 2.2±0.6 over 2 h. However, no appreciable inhibition of killing of E. A commercially prepared, purified mixture of cathepsin G isoenzymes (essentially equivalent to subfractions D8-D 1 by SDS-PAGE analysis) was exposed to the irreversible serine protease inhibitor, DFP. After enzyme inactivation, the DFP was eliminated by microdialysis. Between 96 and 101% inhibition of enzyme activity was estimated below 10 jg/ml (Fig. 8 A) . At 100 ,ug/ml DFP-inactivated cathepsin G, 86% inhibition was calculated, but was innacurate (too low) due to enzyme excess. Bactericidal activity against C. sputigena ATCC 33123 but not E. coli ML-35 was blocked by DFP inactivation (Fig. 8 B) .
Reversed-phase isolation of cathepsin G from subfractions D8-DJ . Subfractions D8-D1 1 were pooled and reseparated using ProRPC reversed-phase FPLC (Fig. 9) . Eight main component peaks were separated (I-VIII), but the majority ofmaterial (> 90%) that absorbed at 280 nm eluted as peak V. Peak V was collected and concentrated by vacuum centrifugation. The resultant peak fraction exhibited two closely spaced bands by acid/urea (AU)-PAGE (Fig. 9, inset) . The amino acid composition of peak V revealed a relatively high proportion of arginyl residues (Table II) (31, 32) . The amino-terminal analysis of peak V was: IIGGRESRPHSRPYMAYLQI, which is consistent with cathepsin G (29) . In comparison, the amino terminal sequence of the major component of subfraction D4 was: IVGGRR-ARPHA, which is consistent with elastase (31), but not cathepsin G, azurocidin, or p29b (10, 11, 18, 32) .
Susceptibility to reversed-phase-purified cathepsin G. We tested the ability of Peak V to kill C. sputigena ATCC 33123. Peak V killed C. sputigena ATCC 33123, but produced > 3.5 bloglo only at 500 sg/ml, which represented a fivefold decrease in cidal potential compared to fraction D and subfraction D9. Additionally, enzymatic activity of peak V was not detectable at ug/ml. Discussion The net effect of the neutrophil is to protect the periodontium against periodontal infection (2). The specific mechanisms tively. The number of residues of D8-Dl 1 was assigned to be consistent with the M, as determined by SDS-PAGE. The number of residues of D4 and peak V was assigned to facilitate comparison with published data for elastase (31) and cathepsin G (32) .
Enzymatic Killing ofCapnocytophaga by Cathepsin G 1589 ,qg/ml. Most bactericidal activity was associated with subfractions D9 and DI10. Subfraction E I represents lysozyme purified from fraction E by Mono-S FPLC, and is included for comparison. "Phos" indicates 10 rnM phosphate buffer, "'tris-Cl" is 10 mM tris containing 140 mM NaCl, and "PBS" indicates 10 mM phosphate containing 140 mM NaCl. All solutions contained 1% TSB and were adjusted to pH 7 .0. Columns and vertical bars represent the mean bloglo and SD6, respectively, of quadruplicate assays.
dative killing mechanisms can require the presence of oxygen to kill microorganisms (38) , presumably to support rapid microbial metabolism during the killing process. Fractions A and E exerted no microbicidal activity against these organisms ei- [NaCI], mM Figure 6 . Effect of NaCl on the bactericidal activity of subfraction D9 (.) and commercially prepared cathepsin G (-) against C. sputigena ATCC 33123 (large graph). Killing was observed below 20 mM NaCl. Buffer controls are also shown (o). Subfraction D9 exhibited cidal activity throughout the tested pH range (inset). Buffer system was 10 mM sodium phosphate. Points and vertical bars represent the mean blogl0 and SD6, respectively, of quadruplicate assays.
ther aerobically or anaerobically. Fractions C and D were microbicidal, but only fraction D was microbicidal under anaerobic conditions and at the concentrations tested. Thus, the components of fraction D may be important in killing oral bacteria within the hypoxic gingival crevice. Fractions F and G, which were also microbicidal against the Capnocytophaga, yielded a number of peptides, including the defensins. Although neither C, D, F, or G were pure, comparisons may be estimated based on assumed molecular weights of 30,000 (for C and D) and 3,000 (for F and G). On a molar basis, the potency ofC and D is -10 times that of F and G. Similarly, we have observed that on a molar basis, the purified defensins, HNP-1, HNP-2, and HNP-3, are -10-20 times less potent than cathepsin G against certain oral bacteria in our assay conditions. Fraction D consisted ofa mixture ofproteins as assessed by activity. Subsequently, other investigators have noted that enzyme activity was not essential in the killing of organisms such as Escherichia coli, Acinetobacter, staphylococci, and gonococci (15, (20) (21) (22) . Recently, azurocidin, a member of the NSP family that lacks enzymatic activity has been discovered (11) . Azurocidin exhibits potent microbicidal activity against nonoral bacteria (10) , suggesting that enzymatic activity is not a necessary requirement for killing of bacteria by certain members of the NSP family.
In this study, we found that enzymatic activity of crude (fraction D), relatively pure (subfraction D9), and commercially purified cathepsin G was associated with microbicidal activity against the oral Capnocytophaga, but not the control organism, E. coli. Persuasively, PMSF-inactivated or DFP-inactivated cathepsin G killed E. coli but not C. sputigena. The microbicidal activities offraction D and subfraction D9 against C. sputigena ATCC 33123 were diminished by heat inactivation, PMSF, and the cathepsin G-specific inhibitor Z-GLPCK. No inhibition of cidal activity was observed in the presence of the solvent vehicle DMSO, or the control chloromethyl ketone TPCK. Some inhibition of the bactericidal activity of fraction D, but not subfraction D9, was also observed with N-MSAAPVCK, the elastase-specific inhibitor. The simplest interpretation of this observation is that the bactericidal activity of fraction D against C. sputigena resulted from a synergistic interaction of both elastase and cathepsin G. Furthermore, the bactericidal activity of elastase was dependent upon cathepsin G, since elastase-containing fractions alone (D3 and D4) exerted no cidal activity. Regardless of the exact interactional properties of cathepsin G and elastase, these results demonstrate that cathepsin G is bactericidal against C. sputigena and that either enzymatic activity and/or an intact enzyme active site is required for killing of C. sputigena.
The reason that the killing of C. sputigena required an intact enzyme active site is unknown. Although this may reflect a requirement for enzymatic activity, it may also reflect the participation of the enzyme active site in the binding of cathepsin G to the surface of C. sputigena. In either case, this is a unique observation. However, there are some clues as to the potential determinant interactions between C. sputigena and cathepsin G that remain to be investigated. It potential target outer membrane proteins (21) . As such, it is possible that unlike previously tested organisms, C. sputigena both possesses LPS that does not confer such masking and also exposes susceptible proteins that must be enzymatically damaged for killing to occur. No inhibition of killing was observed when C. sputigena ATCC 33123 was pretreated with the irreversible serine protease inhibitor PMSF, washed, and exposed to fraction D. We Reversed-phase FPLC on a ProRPC HR 5/2 column. Flow rate was 0.5 ml/min. Absorbance profile at 215 nm is shown, AUFS = 1.28. Eight major peak fractions were observed. Peak V was the predominant peak. By AU-PAGE, peak V revealed two bands (inset), and is shown in comparison to fractions C and D.
surmise that endogenous bacterial proteases were not involved in the cidal effects of fraction D. Also, chymotrypsin A4 could not restore the cidal effects of heat-inactivated subfraction D9. As such, chymotryptic activity alone was not sufficient to kill C. sputigena. Also, it seems more likely that the cationic properties of cathepsin G enabled the enzyme to exert lethal effects, and not that the enzyme prepared the bacterial surface for the lethal effects of a cationic molecule.
We found that pooled subfractions D8-D 1 I compared well in terms of purity with commercially prepared human cathepsin G (> 98% pure) as assessed by SDS-PAGE. Reversed-phase chromatography FPLC using a ProRPC HR 5/2 column (a C I-C4 equivalent) verified that the major component of subfractions D8-D 1 I was cathepsin G. The major peak separated from the subfractions D8-D 11 by reversed-phase chromatography was designated peak V. Peak V represented > 90% of the total material in subfractions D8-D I 1, and produced a doublet banding pattern on AU-PAGE. The high number of arginyl residues, the presence of lysinyl groups, and the NH2-terminal amino acid sequence were consistent with cathepsin G. Peak V represented a more highly purified cathepsin G than subfractions D8-D I 1, yet was about five times less potent against C. sputigena than either fraction D or subfractions D8-D I 1, and exerted no microbicidal activity at 50-100 ,ug/ml. We believe this resulted from the enzymatic inactivation of peak V by the organic solvent and the ion-pairing agent used in the reversedphase separation, acetonitrile, and trifluoroacetic acid (43) . The cidal activity observed at higher concentrations (500 ,ug/ ml) may be ascribable to either nonenzymatic, cationic interactions alone, contaminating azurocidin, or to trace residual enzymatic activity. The first explanation suggests that C. sputigena may be sensitive to two modes of killing by cathepsin G; however, other experimental approaches will be required to resolve these issues.
In summary, oral bacteria of the genus Capnocytophaga were killed in an oxygen-independent fashion by nonoxidative microbicidal systems of human neutrophils, including cathepsin G, a member of the NSP family. Additionally, enzymatic activity was closely associated with the killing of Capnocytophaga by cathepsin G at lower concentrations. This observation suggests that an intact enzyme active site and possibly, w" 20 CL enzymatic activity itself, is involved in the killing of C. sputigena by cathepsin G. We propose that this enzyme-dependent killing of a microorganism by a neutral serine protease represents a heretofore undescribed process and suggest that one of the functions of the chymotryptic activity of cathepsin G is the killing of certain bacteria. Additional research will be required to elucidate the mechanisms of this "enzymatic killing."
